For citations:

Mukhametov U., Lyulin S., Borzunov D., Sufianov R., Gareev I. The risk of tumor with the use of recombinant human bone morphogenetic proteins. Genij Ortopedii. 2022;28(4):592-598. https://doi.org/10.18019/1028-4427-2022-28-4-592-598